Vycor Medical (VYCO) Gross Margin (2010 - 2026)
Vycor Medical's (VYCO) quarterly Gross Margin came in at 81.81% in Q1 2026, down 35.0% year-on-year from 125.87% in Q1 2025, and up 1.7% on a QoQ basis from 80.45% in Q4 2025.
Vycor Medical (VYCO) Gross Margin (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Gross Margin data on file, last reported at 81.81% in Q1 2026.
- On a quarterly basis, Gross Margin fell 35.0% year-over-year to 81.81% in Q1 2026; TTM through Mar 2026 was 83.67%, a 403.0% decrease from a year earlier, with the FY2025 full-year figure at 83.78%, down 573.0% from the prior year.
- Gross Margin for Q1 2026 stood at 81.81%, up from 80.45% in the prior quarter.
- Over the last five years, Gross Margin for VYCO reached as high as 91.76% in Q2 2023 and fell as low as 80.45% in Q4 2025.
- Historically, Gross Margin has averaged 87.47% across 5 years, with a median of 87.96% in 2025.
- Across the five-year window, Gross Margin surged 314 bps in 2023 and sank 768 bps in 2025, its largest moves.
- Year by year, Gross Margin stood at 86.3% in 2022, then gained by 0 bps to 86.37% in 2023, then climbed by 1 bps to 87.29% in 2024, then retreated by 8 bps to 80.45% in 2025, then advanced by 2 bps to 81.81% in 2026.
- Per Business Quant data, the three most recent Gross Margin figures were 81.81% in Q1 2026, 80.45% in Q4 2025, and 87.96% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | 81.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.81% |
| Dec 31, 2025 | 80.45% |
| Sep 30, 2025 | 87.96% |
| Jun 30, 2025 | 83.66% |
| Mar 31, 2025 | 82.16% |
| Dec 31, 2024 | 87.29% |
| Sep 30, 2024 | 90.59% |
| Jun 30, 2024 | 91.35% |
| Mar 31, 2024 | 89.02% |
| Dec 31, 2023 | 86.37% |
| Sep 30, 2023 | 89.52% |
| Jun 30, 2023 | 91.76% |
| Mar 31, 2023 | 91.47% |
| Dec 31, 2022 | 86.30% |
| Sep 30, 2022 | 86.39% |
| Jun 30, 2022 | 91.50% |
| Mar 31, 2022 | 89.35% |
| Dec 31, 2021 | 88.39% |
| Sep 30, 2021 | 89.42% |
| Jun 30, 2021 | 92.00% |